Clinical trial

Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease

NCT06854185

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-02-05

PhaseNA

Study timeline

Study start (actual)2025-02-05Date precision: day

Registry last updated2026-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Dysfunction Associated Steatotic Liver Diseaseunresolved

Overweight (BMI > 25)unresolved

Metabolic Syndromeunresolved

Interventions

Paso ProgramBEHAVIORAL

Sponsors & collaborators

Baylor College of Medicinelead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)collaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06854185 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.